黑料网

Dr. DeLiberty successfully defended his thesis, “Therapeutic Targeting of RAS-Driven Metabolic Dependencies by PIKfyve Inhibition,” under the guidance of Drs. Kirsten Bryant and Channing Der.

Publications

听DeLiberty JM, Roach MK, Stalnecker CA, Robb R, Schechter EG, Pieper NL, Taylor KE, Pita LM, Yang R, Bang S, Drizyte-Miller K, Ackermann SE, Nicewarner Pe帽a SR, Baldelli E, Min SM, Drewry DH, Petricoin EF, Morris JP, Der CJ, Cox AD, Bryant KL. Cancer Res. 2025 Feb 11. . Online ahead of print. PMID:听39932818

Huynh MV, Hobbs GA, Schaefer A, Pierobon M, Carey LM, Diehl JN, DeLiberty JM, Thurman RD, Cooke AR, Goodwin CM, Cook JH, Lin L, Waters AM, Rashid NU, Petricoin EF 3rd, Campbell SL, Haigis KM, Simeone DM, Lyssiotis CA, Cox AD, Der CJ. Sci Signal. 2022 Aug 9; 15(746):eabn2694. . Epub 2022 Aug 9. PMID: 35944066

DeLiberty JM, Robb R, Gates CE, Bryant KL. Adv Cancer Res. 2022; 153:267-304. . Epub 2021 Aug 26. PMID: 35101233 Review.

Stalnecker CA, Grover KR, Edwards AC, Coleman MF, Yang R,听DeLiberty JM, Papke B, Goodwin CM, Pierobon M, Petricoin EF, Gautam P, Wennerberg K, Cox AD, Der CJ, Hursting SD, Bryant KL.Cancer Res. 2022 Feb 15; 82(4):586-598. . PMID: 34921013

Klomp JE, Lee YS, Goodwin CM, Papke B, Klomp JA, Waters AM, Stalnecker CA,听DeLiberty JM, Drizyte-Miller K, Yang R, Diehl JN, Yin HH, Pierobon M, Baldelli E, Ryan MB, Li S, Peterson J, Smith AR, Neal JT, McCormick AK, Kuo CJ, Counter CM, Petricoin EF 3rd, Cox AD, Bryant KL, Der CJ.听 Cell Rep. 2021 Nov 30; 37(9):110060. doi: . PMID: 34852220

Fletcher R, Tong J, Risnik D, Leibowitz BJ, Wang YJ, Concha-Benavente F,听DeLiberty JM, Stolz DB, Pai RK, Ferris RL, Schoen RE, Yu J, Zhang L. Oncogene. 2021 Mar; 40(11):2035-2050. . Epub 2021 Feb 18. PMID: 33603166

Hobbs GA, Baker NM, Miermont AM, Thurman RD, Pierobon M, Tran TH, Anderson AO, Waters AM, Diehl JN, Papke B, Hodge RG, Klomp JE, Goodwin CM,听DeLiberty JM, Wang J, Ng RWS, Gautam P, Bryant KL, Esposito D, Campbell SL, Petricoin EF 3rd, Simanshu DK, Aguirre AJ, Wolpin BM, Wennerberg K, Rudloff U, Cox AD, Der CJ. Cancer Discov. 2020 Jan; 10(1):104-123. . Epub 2019 Oct 24. PMID: 31649109

UPDATE: Dr. DeLiberty’s first authored research paper was published in Cancer Research journal on Feb. 11, 2025.听 (It has been added as the first paper listed above).

Deliberty has accepted a Postdoctoral position at the Dana-Farber Cancer Institute, where he will be co-mentored by Joe Mancias and Andy Aguirre.

Honors, Awards & Highlights

American Association for Cancer Research (AACR) Scholar-in-Training Award, 2024

An award supported by Let鈥檚 Win Pancreatic Cancer that supported attending the AACR Special Conference in Advances in Pancreatic Cancer Research Boston, MA.

Best Oral Presentation, Pharmacology Retreat, 2023

Pharmacology Student Scholar, 2022

Second Place for Best Graduate,听黑料网 Integrated Training in Cancer Model Systems, 2022

TIBBS ImPACT Scholar, 黑料网 Training Initiatives in Biomedical and Biological Sciences, 2022
Award to support doing an internship during my graduate studies

Congratulations, Jonathan! We wish you all the best!